Trials / Unknown
UnknownNCT06262880
Dietary Supplementation on Gastrointestinal Barrier Function
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Effects of a Dietary Supplement Containing N-trans-Caffeoyltyramine (NCT) and N-trans-Feruloyltyramine (NFT) on Gastrointestinal Barrier Function
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 126 (estimated)
- Sponsor
- Brightseed · Industry
- Sex
- All
- Age
- 30 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels on parameters of gastrointestinal (GI) health in otherwise generally healthy adults with risk factors (high BMI and waist circumference) for increased GI permeability. The primary hypothesis is that supplementation with plant derived phenolics will improve gut health compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | plant derived phenolics | Dietary supplement containing plant derived phenolics |
| OTHER | Microcrystaline cellulose (MCC) | Placebo treatment: Microcrystaline cellulose |
Timeline
- Start date
- 2024-02-06
- Primary completion
- 2024-12-20
- Completion
- 2025-02-06
- First posted
- 2024-02-16
- Last updated
- 2024-03-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06262880. Inclusion in this directory is not an endorsement.